Weber, Johanna
Scholz, Konstantin J.
Schenke, Isabelle M.
Pfab, Florian
Cieplik, Fabian
Hiller, Karl-Anton
Buchalla, Wolfgang
Sahm, Camilla
Kirschneck, Christian
Paddenberg-Schubert, Eva
Funding for this research was provided by:
Clevergum GmbH
Universitätsklinikum Regensburg
Article History
Received: 22 February 2024
Accepted: 21 April 2024
First Online: 25 April 2024
Declarations
:
: The study design was approved by the Internal Review Board (IRB) of the University of Regensburg (Ref. 22-2952-101) in accordance with the 1964 Declaration of Helsinki and its subsequent amendments or comparable ethical standards. The study was prospectively registered in the German Clinical Trials Registry (Ref. DRKS00030056).
: Written informed consent was obtained from all individual patients included in this study.
: This study was an investigator-initiated trial funded in part by Clevergum GmbH (GrĂĽnwald, Germany) and Florian Pfab is a shareholder of this company. All other authors declare that they have no conflicts of interest.